{"id":"https://openalex.org/W192769413","doi":"https://doi.org/10.1097/00006454-199907000-00008","title":"Efficacy and safety of ampicillin/sulbactam and cefuroxime in the treatment of serious skin and skin structure infections in pediatric patients","display_name":"Efficacy and safety of ampicillin/sulbactam and cefuroxime in the treatment of serious skin and skin structure infections in pediatric patients","publication_year":1999,"publication_date":"1999-07-01","ids":{"openalex":"https://openalex.org/W192769413","doi":"https://doi.org/10.1097/00006454-199907000-00008","mag":"192769413","pmid":"https://pubmed.ncbi.nlm.nih.gov/10440436"},"language":"en","primary_location":{"id":"doi:10.1097/00006454-199907000-00008","doi":"https://doi.org/10.1097/00006454-199907000-00008","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00006454-199907000-00008","pdf_url":null,"source":{"id":"https://openalex.org/S109369870","display_name":"The Pediatric Infectious Disease Journal","issn_l":"0891-3668","issn":["0891-3668","1532-0987"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Pediatric Infectious Disease Journal","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057792641","display_name":"Parvin H. Azimi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1314135232","display_name":"Nationwide Children's Hospital","ror":"https://ror.org/003rfsp33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1314135232"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I26347476","display_name":"Loma Linda University","ror":"https://ror.org/04bj28v14","country_code":"US","type":"education","lineage":["https://openalex.org/I26347476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"PARVIN H. AZIMI","raw_affiliation_strings":["Division of Infectious Diseases, Children's Hospital, Oakland, CA, USA","Accepted for publication April 1, 1999","Department of Pediatrics, Loma Linda University, Loma Linda, CA (DJ)","From the Division of Infectious Diseases, Children's Hospital, Oakland, CA (PA)","Pfizer Inc., New York, NY (RS)","Reprints not available","Section of Infectious Diseases, Children's Hospital, Columbus, OH (WB)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Diseases, Children's Hospital, Oakland, CA, USA","institution_ids":[]},{"raw_affiliation_string":"Accepted for publication April 1, 1999","institution_ids":[]},{"raw_affiliation_string":"Department of Pediatrics, Loma Linda University, Loma Linda, CA (DJ)","institution_ids":["https://openalex.org/I26347476"]},{"raw_affiliation_string":"From the Division of Infectious Diseases, Children's Hospital, Oakland, CA (PA)","institution_ids":[]},{"raw_affiliation_string":"Pfizer Inc., New York, NY (RS)","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Reprints not available","institution_ids":[]},{"raw_affiliation_string":"Section of Infectious Diseases, Children's Hospital, Columbus, OH (WB)","institution_ids":["https://openalex.org/I1314135232"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041255852","display_name":"William J. Barson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1314135232","display_name":"Nationwide Children's Hospital","ror":"https://ror.org/003rfsp33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1314135232"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I26347476","display_name":"Loma Linda University","ror":"https://ror.org/04bj28v14","country_code":"US","type":"education","lineage":["https://openalex.org/I26347476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"WILLIAM J. BARSON","raw_affiliation_strings":["Department of Pediatrics, Loma Linda University, Loma Linda, CA (DJ)","From the Division of Infectious Diseases, Children's Hospital, Oakland, CA (PA)","Section of Infectious Diseases, Children's Hospital, Columbus, OH (WB)","Accepted for publication April 1, 1999","Pfizer Inc., New York, NY (RS)","Reprints not available"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, Loma Linda University, Loma Linda, CA (DJ)","institution_ids":["https://openalex.org/I26347476"]},{"raw_affiliation_string":"From the Division of Infectious Diseases, Children's Hospital, Oakland, CA (PA)","institution_ids":[]},{"raw_affiliation_string":"Section of Infectious Diseases, Children's Hospital, Columbus, OH (WB)","institution_ids":["https://openalex.org/I1314135232"]},{"raw_affiliation_string":"Accepted for publication April 1, 1999","institution_ids":[]},{"raw_affiliation_string":"Pfizer Inc., New York, NY (RS)","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Reprints not available","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052017127","display_name":"Donald Janner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1314135232","display_name":"Nationwide Children's Hospital","ror":"https://ror.org/003rfsp33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1314135232"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I26347476","display_name":"Loma Linda University","ror":"https://ror.org/04bj28v14","country_code":"US","type":"education","lineage":["https://openalex.org/I26347476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"DONALD JANNER","raw_affiliation_strings":["Department of Pediatrics, Loma Linda University, Loma Linda, CA (DJ)","From the Division of Infectious Diseases, Children's Hospital, Oakland, CA (PA)","Section of Infectious Diseases, Children's Hospital, Columbus, OH (WB)","Accepted for publication April 1, 1999","Pfizer Inc., New York, NY (RS)","Reprints not available"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, Loma Linda University, Loma Linda, CA (DJ)","institution_ids":["https://openalex.org/I26347476"]},{"raw_affiliation_string":"From the Division of Infectious Diseases, Children's Hospital, Oakland, CA (PA)","institution_ids":[]},{"raw_affiliation_string":"Section of Infectious Diseases, Children's Hospital, Columbus, OH (WB)","institution_ids":["https://openalex.org/I1314135232"]},{"raw_affiliation_string":"Accepted for publication April 1, 1999","institution_ids":[]},{"raw_affiliation_string":"Pfizer Inc., New York, NY (RS)","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Reprints not available","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"ROBERT SWANSON","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1314135232","display_name":"Nationwide Children's Hospital","ror":"https://ror.org/003rfsp33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1314135232"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I26347476","display_name":"Loma Linda University","ror":"https://ror.org/04bj28v14","country_code":"US","type":"education","lineage":["https://openalex.org/I26347476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"ROBERT SWANSON","raw_affiliation_strings":["Department of Pediatrics, Loma Linda University, Loma Linda, CA (DJ)","From the Division of Infectious Diseases, Children's Hospital, Oakland, CA (PA)","Section of Infectious Diseases, Children's Hospital, Columbus, OH (WB)","Accepted for publication April 1, 1999","Pfizer Inc., New York, NY (RS)","Reprints not available"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, Loma Linda University, Loma Linda, CA (DJ)","institution_ids":["https://openalex.org/I26347476"]},{"raw_affiliation_string":"From the Division of Infectious Diseases, Children's Hospital, Oakland, CA (PA)","institution_ids":[]},{"raw_affiliation_string":"Section of Infectious Diseases, Children's Hospital, Columbus, OH (WB)","institution_ids":["https://openalex.org/I1314135232"]},{"raw_affiliation_string":"Accepted for publication April 1, 1999","institution_ids":[]},{"raw_affiliation_string":"Pfizer Inc., New York, NY (RS)","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Reprints not available","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.02511944,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"18","issue":"7","first_page":"609","last_page":"613"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.5396000146865845,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.5396000146865845,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.23100000619888306,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11153","display_name":"Streptococcal Infections and Treatments","score":0.06469999998807907,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ampicillin-sulbactam","display_name":"ampicillin-sulbactam","score":0.9940000176429749},{"id":"https://openalex.org/keywords/cefuroxime","display_name":"cefuroxime","score":1.0},{"id":"https://openalex.org/keywords/skin-and-skin-structure-infections","display_name":"skin and skin structure infections","score":0.8619999885559082},{"id":"https://openalex.org/keywords/pediatric-patients","display_name":"pediatric patients","score":0.8040000200271606},{"id":"https://openalex.org/keywords/beta-lactam-beta-lactamase-inhibitors","display_name":"beta-lactam/beta-lactamase inhibitors","score":0.8569999933242798},{"id":"https://openalex.org/keywords/empirical-antibiotic-therapy","display_name":"empirical antibiotic therapy","score":0.7400000095367432},{"id":"https://openalex.org/keywords/parenteral-antimicrobial-therapy","display_name":"parenteral antimicrobial therapy","score":0.746999979019165},{"id":"https://openalex.org/keywords/antimicrobial-efficacy","display_name":"antimicrobial efficacy","score":0.6980000138282776},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.746999979019165},{"id":"https://openalex.org/keywords/coinfection","display_name":"co-infection","score":0.7210000157356262}],"concepts":[{"id":"https://openalex.org/C2777514703","wikidata":"https://www.wikidata.org/wiki/Q413728","display_name":"Cefuroxime","level":3,"score":0.9334605932235718},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8740279674530029},{"id":"https://openalex.org/C2778478555","wikidata":"https://www.wikidata.org/wiki/Q423393","display_name":"Sulbactam","level":5,"score":0.8684170246124268},{"id":"https://openalex.org/C2776021129","wikidata":"https://www.wikidata.org/wiki/Q244150","display_name":"Ampicillin","level":3,"score":0.785498857498169},{"id":"https://openalex.org/C64778159","wikidata":"https://www.wikidata.org/wiki/Q271021","display_name":"Cephalosporin","level":3,"score":0.5225764513015747},{"id":"https://openalex.org/C4937899","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Antimicrobial","level":2,"score":0.49484890699386597},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.4747602939605713},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4391757845878601},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.371765673160553},{"id":"https://openalex.org/C94665300","wikidata":"https://www.wikidata.org/wiki/Q63391344","display_name":"Antibiotic resistance","level":3,"score":0.09617042541503906},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.07430800795555115},{"id":"https://openalex.org/C2779631663","wikidata":"https://www.wikidata.org/wiki/Q425152","display_name":"Imipenem","level":4,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000667","descriptor_name":"Ampicillin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000667","descriptor_name":"Ampicillin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002444","descriptor_name":"Cefuroxime","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002444","descriptor_name":"Cefuroxime","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002511","descriptor_name":"Cephalosporins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002511","descriptor_name":"Cephalosporins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007223","descriptor_name":"Infant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013407","descriptor_name":"Sulbactam","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013407","descriptor_name":"Sulbactam","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017192","descriptor_name":"Skin Diseases, Bacterial","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/00006454-199907000-00008","doi":"https://doi.org/10.1097/00006454-199907000-00008","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00006454-199907000-00008","pdf_url":null,"source":{"id":"https://openalex.org/S109369870","display_name":"The Pediatric Infectious Disease Journal","issn_l":"0891-3668","issn":["0891-3668","1532-0987"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Pediatric Infectious Disease Journal","raw_type":"journal-article"},{"id":"pmid:10440436","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10440436","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Pediatric infectious disease journal","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.8199999928474426,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":13,"referenced_works":["https://openalex.org/W56553380","https://openalex.org/W82057326","https://openalex.org/W1964004587","https://openalex.org/W1972020615","https://openalex.org/W1981050914","https://openalex.org/W2024430469","https://openalex.org/W2026559683","https://openalex.org/W2028304474","https://openalex.org/W2044768822","https://openalex.org/W2150503785","https://openalex.org/W2270858753","https://openalex.org/W2426142685","https://openalex.org/W3093696874"],"related_works":["https://openalex.org/W2426142685","https://openalex.org/W2270858753","https://openalex.org/W1990726243","https://openalex.org/W2170871707","https://openalex.org/W1991085983","https://openalex.org/W2004090970","https://openalex.org/W2082001211","https://openalex.org/W3030630476","https://openalex.org/W2280828127","https://openalex.org/W2401452256"],"abstract_inverted_index":{"BACKGROUND:":[0],"Pediatric":[1],"skin":[2,4,48,50,250,252],"and":[3,10,31,40,49,55,159,182,207,229,236,240,251],"structure":[5,51,253],"infections":[6,52],"are":[7],"often":[8],"polymicrobial":[9],"require":[11],"empiric":[12],"therapy":[13,244],"effective":[14,241],"against":[15],"pathogens":[16,193],"that":[17,70],"may":[18],"be":[19],"resistant":[20],"to":[21,83,103,123],"many":[22],"antimicrobial":[23,57,132],"agents.":[24],"The":[25,166],"present":[26],"study":[27],"tested":[28],"the":[29,135,150,170,188],"efficacy":[30],"safety":[32],"of":[33,78,101,149,190,201,210],"a":[34,41,62,99],"parenteral":[35,56,242],"beta-lactam/beta-lactamase":[36],"inhibitor":[37],"combination,":[38],"ampicillin/sulbactam,":[39],"beta-lactamase-stable":[42],"cephalosporin,":[43],"cefuroxime,":[44],"in":[45,87,98,110,222,245],"serious":[46,249],"pediatric":[47,246],"requiring":[53],"hospitalization":[54],"therapy.":[58],"METHODS:":[59],"This":[60],"was":[61,96,121],"multicenter,":[63],"randomized,":[64],"prospective,":[65],"comparative":[66],"open":[67],"label":[68],"trial":[69],"enrolled":[71],"patients":[72,153,173,203,247],"3":[73],"months":[74],"through":[75],"11":[76],"years":[77],"age.":[79],"Patients":[80,127],"received":[81,155,213],"150":[82],"300":[84],"mg/kg/day":[85,105],"ampicillin/sulbactam":[86,156,206,228,235],"equally":[88,111],"divided":[89,112],"intravenous":[90],"doses":[91,113],"every":[92,114],"6":[93,115],"h.":[94,118],"Cefuroxime":[95],"given":[97],"dosage":[100],"50":[102],"100":[104],"either":[106],"intravenously":[107],"or":[108,116,224],"intramuscularly":[109],"8":[117],"Maximum":[119],"treatment":[120,133,191],"not":[122],"exceed":[124],"14":[125],"days.":[126],"could":[128],"receive":[129],"subsequent":[130],"oral":[131],"at":[134],"investigator's":[136],"discretion.":[137],"RESULTS:":[138],"At":[139,187],"final":[140],"evaluation":[141],"for":[142,169],"clinical":[143,223],"efficacy,":[144],"78.0%":[145],"(n":[146,161,179,184,198],"=":[147,162,180,185,199],"46)":[148],"59":[151,202],"evaluable":[152,172],"who":[154,212],"were":[157,164,177,194,216,231],"cured":[158],"22.0%":[160],"13)":[163],"improved.":[165],"respective":[167],"values":[168],"39":[171,211],"treated":[174,204],"with":[175,205,248],"cefuroxime":[176,230,237],"76.9%":[178],"30)":[181],"23.1%":[183],"9).":[186],"end":[189],"all":[192],"eradicated":[195],"from":[196,208],"93.2%":[197],"55)":[200],"100%":[209],"cefuroxime.":[214],"There":[215],"no":[217],"significant":[218],"differences":[219],"between":[220],"treatments":[221],"bacteriologic":[225],"efficacy.":[226],"Both":[227,234],"well-tolerated.":[232],"CONCLUSION:":[233],"provide":[238],"safe":[239],"antibiotic":[243],"infections.":[254]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}